/PRNewswire/ CLL Society, the world s leading authority for chronic lymphocytic leukemia and small lymphocytic lymphoma patients, is proud to announce the.
/PRNewswire/ CLL Society made significant progress last year in providing critical information and support for patients with chronic lymphocytic leukemia.
The Food and Drug Administration is reviewing a new antibody drug from AstraZeneca that could significantly improve protection for people at the highest risk: those with compromised immune systems.